Vetivex 1 (9 mg/ml) solution for infusion for cattle, horses, dogs and cats

Riik: Iirimaa

keel: inglise

Allikas: HPRA (Health Products Regulatory Authority)

Toimeaine:

Sodium chloride

Saadav alates:

Dechra Regulatory B.V.

ATC kood:

QB05BB01

INN (Rahvusvaheline Nimetus):

Sodium chloride

Annus:

9 milligram(s)/millilitre

Ravimvorm:

Solution for infusion

Retsepti tüüp:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutiline ala:

electrolytes

Volitamisolek:

Authorised

Loa andmise kuupäev:

2013-08-09

Toote omadused

1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
VETIVEX 1 (9 mg/ml) solution for infusion for cattle, horses, dogs and
cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1 ml dose contains:
ACTIVE SUBSTANCE:
Sodium Chloride
9 mg
Sodium: 150 mmol/litre
Chloride: 150 mmol/litre
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for infusion.
Clear, colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, horses, dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
This product is administered by intravenous infusion for the treatment
of dehydration
in cattle, horses, dogs and cats. It may be used to correct
hypovolaemia resulting
from shock or gastrointestinal disease (especially where metabolic
alkalosis is
present, e.g. in cases of sustained vomiting or abomasal disorders in
cattle). It may
be administered to meet normal fluid and electrolyte requirements when
fluids cannot
be given orally.
4.3
CONTRAINDICATIONS
Do not use in animals with:
-
hypernatraemia
-
hyperchloraemia
-
hyperhydration
-
oedema (hepatic, renal, or cardiac)
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals:
Do not use unless the solution is clear, free from visible particles
and the container is
undamaged.
Sodium overload may occur in animals with cardiac or renal impairment.
It should be
noted that sodium excretion may be impaired post-surgery/trauma.
A risk of thrombosis with intravenous infusion should be considered.
Maintain aseptic precautions.
The product should be warmed to approximately 37
°
C prior to the administration of
large volumes, or if the administration rate is high, in order to
avoid hypothermia.
Use with caution in animals with hypokalaemia.
Serum electrolyte levels, water and acid-base balance and the clinical
condition of
the animal should be closely monitored during the treatment in order
to prevent
overdose, particularly in cases of renal or metabolic changes.
This product should not be